Q2. What are the future works in "Prevalence of gestational diabetes mellitus in europe: a meta- analysis" ?
Nevertheless, given the changing migration patterns across Europe, this prevalence estimate may well change in the future. The IADPSG guidelines suggest that all women or those at high risk have either fasting blood glucose, A1c or random blood glucose measured at the first prenatal visit and overt diabetes diagnosed if fasting blood glucose is 126mg/dl or higher or A1c 6. 5 % or higher [ 56 ]. Therefore, although estimates of GDM may be inflated by the potential inclusion of women with undiagnosed pre-existing diabetes, given the low prevalence of this it is unlikely that the effect on GDM estimates would be large.
Q3. What is the strength of the present study?
A strength of the present study is that pooling studies using meta-analysis allows trends to be identified when there are inconsistencies between individual studies.
Q4. What is the main reason for the increase in GDM prevalence?
With GDM being closely linked to type 2 diabetes mellitus and sharing some risk factors, the authors would expect to see an increase in GDM over time [1].
Q5. How long after a pregnancy is the incidence of type 2 diabetes mellitus?
Women are thought to be at the greatest risk of developing type 2 diabetes mellitus in the first five years following a pregnancy with GDM, with incidence of type 2 diabetes mellitus plateauing at around 10 years [6].
Q6. What was the definition of a study that was drawn from the general population of pregnant women?
Studies were defined as having a sample drawn from the general population of pregnant women if it was drawn from a source that covered the majority of the population, such as population registers, general practice registers or registers of clinics for pregnant women (in countries where registration at general practices and clinics for pregnancy women is near to universal).
Q7. What were the limitations of the methodology?
The methodology had only minor limitations: only papers published in the English language were included, experts in the field were not contacted, grey literature was not identified and data extraction was only carried out by one author.
Q8. What criteria were used to determine the prevalence of diabetes mellitus?
The prevalence estimate deriving from the criteria that were most commonly used in other papers in the review was the one selected for inclusion in the meta-analysis so that the estimate would be comparable to other studies in the review.
Q9. What were the main factors that had a significant effect on the prevalence of GDM?
Sample age, diagnostic criteria, country the study was conducted in, year that data collection started and week of gestation at testing, all had a significant effect on the prevalence of GDM, whereas the quality category of studies, mean BMI, ethnicity, and family history of diabetes in samples, did not have a significant effect.
Q10. What criteria were used to assess the quality of included studies?
The quality of included studies was assessed using a checklist based upon the example published by the Joanna Briggs Institute [12] which was designed for assessment of quality in systematic reviews of prevalence and incidence.
Q11. Why was the prevalence estimate included in the meta-analysis?
Where individual studies reported multiple prevalence estimates according to different diagnostic criteria, only one prevalence estimate was included in the meta-analysis to avoid dependency effects.